NeuroOne filed its FDA 510(k) for trigeminal nerve ablation months ahead of its revised May 2025 timeline. OneRF system targets trigeminal neuralgia, a condition impacting ~100K in the U.S., using ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on Wednesday, earlier than previously guided. NeuroOne Medical is ...

The following is a summary of “Suicidal Ideation and Self-Injury in Trigeminal Neuralgia,” published in the April 2025 issue of Journal of Pain Research by Fishbein et al. Researchers conducted a ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology. The submission comes in ahead of schedule for the Eden Prairie ...

April 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and ...

This submission leverages the Company's proprietary OneRF ® Ablation System RF generator platform for the treatment of trigeminal neuralgia, a chronic pain condition affecting approximately ...

The convergent inputs to the central projection of the trigeminovascular system, the trigeminal nucleus caudalis and the C1 and C2 regions of the spinal cord, collectively known as the ...

The specific area that this cranial nerve comes from is called the abducens nucleus. It then: A small branch of the abducens nerve also connects to the contralateral medial rectus muscle. This allows ...

3. Trigeminal neuralgia: When nerve pain strikes Trigeminal neuralgia represents one of the most distinctive and debilitating causes of one-sided facial and head pain. This condition involves the ...